ISSN: 1746-0913

Journal Home

Journal Guideline

Future Microbiology Q3 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Future Microbiology is a journal indexed in SJR in Microbiology and Microbiology (medical) with an H index of 107. It has an SJR impact factor of 0,539 and it has a best quartile of Q3. It has an SJR impact factor of 0,539.

Future Microbiology focuses its scope in these topics and keywords: drug, impact, mycobacterium, pathogenesis, proteins, putative, staphylococcus, tuberculosisevolutionary, arenaviral, argenteus, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Microbiology (Q3) Microbiology (medical) (Q3) Microbiology (medical) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,539

SJR Impact factor

107

H Index

134

Total Docs (Last Year)

389

Total Docs (3 years)

7393

Total Refs

805

Total Cites (3 years)

359

Citable Docs (3 years)

2.09

Cites/Doc (2 years)

55.17

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Microbiology and Immunology Q3
Brazilian Journal of Microbiology Q3
FEMS Microbiology Letters Q3
Advances in Microbial Physiology Q3
Letters in Applied Microbiology Q3

Compare this journals

Aims and Scope

Best articles by citations

Adherence to Surgical Care Improvement Project measures: the whole is greater than the parts

Cumulative irritation, sensitizing potential, phototoxicity and photoallergy of ozenoxacin in healthy adult volunteers

Immune response toAspergillus fumigatusin compromised hosts: from bedside to bench

Epstein-Barr virus and multiple sclerosis: causation or association?

Artemisinin-resistantPlasmodium falciparum: can the genie be put back in the bottle?

Giving a voice to those who die young: the fatal impact of tuberculosis and HIV in South Africa

Contaminated water delivery as a simple and effective method of experimental Salmonella infection

Development of humanized mouse models to study human malaria parasite infection

5'-UTR ofmalSincreases the invasive capacity ofSalmonella entericaserovar Typhi by influencing the expression ofbax

Influenza B viruses: not to be discounted

Evaluation of phenotypic and molecular methods for identification ofStreptococcus pneumoniae

Etiological diagnosis of pericardial effusion

SHOW MORE ARTICLES

In vitropercutaneous absorption and metabolism of ozenoxacin in excised human skin

MALDI-TOF mass spectrometry-based direct-on-target microdroplet growth assay: a novel assay for susceptibility testing and beyond

Emerging resistance in Gram-negative pathogens and implications for clinical practice

Viruses and human breast cancer

High respiratory virus oropharyngeal carriage rate duringKingella kingaeosteoarticular infections in children

Insights intoStreptococcus pyogenespathogenesis from transcriptome studies

Ozenoxacin: a review of absorption, dermal exposure and toxicity, tolerability and safety studies

Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye

Small noncoding RNA: novel targets for antiviral therapy

Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials

Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model?

Anidulafungin: a novel echinocandin for candida infections